Skip to main content
Caplight Logo









Treatibles

Treatibles

Private
Sonoma, CaliforniaConsumer & Commercehttps://treatibles.com/

Last Round

Early Funding

Aug 1, 2014

Total Funding Raised

$1.25M

Company Overview

Treatibles operates in Consumer & Commerce and is based in Sonoma, California. Its latest recorded funding round was an Early Funding round in August 2014.

Treatibles is a pet wellness company that produces and sells organic, full-spectrum hemp-derived CBD products including chews, oils, and topicals for pets.

Sector

Consumer & Commerce

Verticals

D2C Brands, Home & Lifestyle, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Treatibles Comparables

Compare Treatibles with similar companies based on industry and business-model similarity.

Treatibles comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Canna-Pet
93%
Austin and Kat
93%
HolistaPet
92%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Treatibles Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingAug 1, 2014
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Treatibles Investors

Notable investors and investment history

Treatibles investors
InvestorRounds
Poseidon Asset ManagementEarly Funding
The Arcview GroupEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2025

    Monthly visitors grew 92% MoM, reaching 8.6K.

  • May 4, 2025

    Monthly visitors grew 128% MoM, reaching 13.2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Treatibles Filings

Explore SEC and related filing metadata, where available.

Treatibles filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Treatibles's valuation, stock price, and market status.

Is Treatibles a public or private company?

Treatibles is a private company.

What is the current stock price of Treatibles?

Treatibles is a private company, so its shares have no public market price. Caplight tracks Treatibles's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Treatibles worth (valuation)?

Valuation information for Treatibles is not publicly available.

Can I buy Treatibles stock?

Treatibles shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Treatibles's last funding round?

Treatibles's most recent funding round was Early Funding on August 1, 2014.

Who are the main investors in Treatibles?

Key investors in Treatibles include Poseidon Asset Management, The Arcview Group.

Will Treatibles IPO soon?

No public IPO plans have been announced for Treatibles.

How can I track Treatibles secondary market activity?

Caplight tracks bids, offers, and trades in Treatibles's shares on secondary markets.

Firmographic Details

HeadquartersSonoma, California
Employee Range8
Year Founded2013
Last FundingAug 1, 2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?